We chose to examine the impact of myeloid-specific JAM-A deletion in the syngeneic LLC and Py8119 tumor models because these tumors are heavily infiltrated by myeloid cells, similar to the majority of human lung and breast tumors (34, 35). Here, F11R is linked to breast neoplasm.